Singleron to present novel single cell sequencing solutions for blood cancer research at the 64th ASH Annual Meeting & Exposition
14. November 2022 03:00 ET
|
Singleron Biotechnologies GmbH
COLOGNE, Germany, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions for precision...
Singleron opens a new state-of-the-art laboratory to showcase the latest single cell sequencing technology
07. November 2022 03:00 ET
|
Singleron Biotechnologies Pte. Ltd.
COLOGNE, Germany, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a leader in single cell multi-omics analysis, is happy to announce the opening of their brand-new laboratories in...
First commercial kit to quantify protein modification in single cells launched by Singleron Biotechnologies
03. November 2022 10:00 ET
|
Singleron Biotechnologies Pte. Ltd.
COLOGNE, Germany, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions, announces the...
Singleron supports Project Maleth’s second mission MALETH II by analyzing biological samples sent to space
14. Juli 2022 23:00 ET
|
Singleron Biotechnologies Pte. Ltd.
COLOGNE, Germany, July 14, 2022 (GLOBE NEWSWIRE) -- Maleth Program is the first space bioscience project led by Professor Joseph Borg of the University of Malta. The second mission under the Maleth...
Proteona opens new laboratory in Singapore
10. Mai 2022 21:01 ET
|
Proteona
SINGAPORE, May 10, 2022 (GLOBE NEWSWIRE) -- Proteona Pte. Ltd., a subsidiary of Singleron Biotechnologies, and a leader in single-cell multi-omics analysis, today announced the opening of a new...
Proteona announces multiple ASH presentations highlighting novel gene signatures in hematological cancers identified using advanced single-cell biomarker discovery platform
08. Dezember 2021 06:38 ET
|
Proteona
SINGAPORE, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Proteona, a single-cell precision medicine company, today announced that three abstracts from the company and its collaborators have been accepted for...